Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
Journal of Human Genetics
|
March 8, 2019
Previously undescribed thyroid-specific miRNA sequences in papillary thyroid carcinoma
Mateus Camargo Barros-Filho, Michelle Pewarchuk, Brenda de Carvalho Minatel, et al.
Toxics
|
September 27, 2025
Toxicological, Chemical, Social, and Economic Challenges Associated with PFAS and Replacement Aqueous Film-Forming Foams (AFFF)
William S Baldwin, Michael S Bloom, Katy W Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 19, 2021
Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy
Aaron J Grossberg, Crosby D Rock, Jared Edwards, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 5, 2017
Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions
Abdallah S R Mohamed, Carlos E Cardenas, Adam S Garden, et al.
Journal of Medicinal Chemistry
|
September 23, 2000
(S)-4-Methyl-2-(methylamino)pentanoic acid [4, 4-bis(4-fluorophenyl)butyl]amide hydrochloride, a novel calcium channel antagonist, is efficacious in several animal models of pain
Y Song, S S Bowersox, D T Connor, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 2022
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers
Mark P Rubinstein, Cameron Williams, Caroline Mart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2018
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors
Kim Margolin, Chihiro Morishima, Vamsidhar Velcheti, et al.
JCI Insight
|
July 13, 2021
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions
J Silvio Gutkind, Alfredo A Molinolo, Xingyu Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2021
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma
Jennifer A Foltz, Brian T Hess, Veronika Bachanova, et al.
Oral Oncology
|
March 31, 2018
Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer
Mona Kamal, Sweet Ping Ng, Salman A Eraj, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
Journal of Human Genetics
|
March 8, 2019
Previously undescribed thyroid-specific miRNA sequences in papillary thyroid carcinoma
Mateus Camargo Barros-Filho, Michelle Pewarchuk, Brenda de Carvalho Minatel, et al.
Toxics
|
September 27, 2025
Toxicological, Chemical, Social, and Economic Challenges Associated with PFAS and Replacement Aqueous Film-Forming Foams (AFFF)
William S Baldwin, Michael S Bloom, Katy W Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 19, 2021
Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy
Aaron J Grossberg, Crosby D Rock, Jared Edwards, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 5, 2017
Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions
Abdallah S R Mohamed, Carlos E Cardenas, Adam S Garden, et al.
Journal of Medicinal Chemistry
|
September 23, 2000
(S)-4-Methyl-2-(methylamino)pentanoic acid [4, 4-bis(4-fluorophenyl)butyl]amide hydrochloride, a novel calcium channel antagonist, is efficacious in several animal models of pain
Y Song, S S Bowersox, D T Connor, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 2022
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers
Mark P Rubinstein, Cameron Williams, Caroline Mart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2018
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors
Kim Margolin, Chihiro Morishima, Vamsidhar Velcheti, et al.
JCI Insight
|
July 13, 2021
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions
J Silvio Gutkind, Alfredo A Molinolo, Xingyu Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2021
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma
Jennifer A Foltz, Brian T Hess, Veronika Bachanova, et al.
Oral Oncology
|
March 31, 2018
Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer
Mona Kamal, Sweet Ping Ng, Salman A Eraj, et al.
Page
of 17